# Lexicon Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed May 8, 2026

- Company: [Lexicon Pharmaceuticals, Inc.](/companies/lxrx.md) (CIK 1062822)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-08
- Accepted by EDGAR: May 8, 2026, 21:42 ET
- Period: not reported
- Accession: 0001193125-26-215295
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1062822/000119312526215295/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1062822/000119312526215295/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1062822/000119312526215295/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-215295. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.
